Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Diseases of the Thyroid

  Free Subscription


Articles published in Endocr J

Retrieve available abstracts of 85 articles:
HTML format



Single Articles


    September 2022
  1. NAGAYAMA Y, Nishihara E
    Thyrotropin receptor antagonists and inverse agonists, and their potential application to thyroid diseases.
    Endocr J. 2022 Sep 27. doi: 10.1507/endocrj.EJ22-0391.
    PubMed     Abstract available


  2. FUJITA N, Ono Y, Kobayashi T, Kozono S, et al
    Iodine-containing ointment-induced hypothyroidism in a patient with anorexia nervosa and sacral decubitus ulcer: a case report with literature review.
    Endocr J. 2022 Sep 3. doi: 10.1507/endocrj.EJ22-0248.
    PubMed     Abstract available


    August 2022
  3. CHAUDHARY S, Dogra V, Walia R
    Four cases of Graves' disease following viral vector severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) vaccine.
    Endocr J. 2022 Aug 18. doi: 10.1507/endocrj.EJ22-0208.
    PubMed     Abstract available


    July 2022
  4. OHBA K, Iwaki T
    Role of thyroid hormone in an experimental model of atherosclerosis: the potential mediating role of immune response and autophagy.
    Endocr J. 2022 Jul 23. doi: 10.1507/endocrj.EJ22-0177.
    PubMed     Abstract available


  5. FUSE Y, Ito Y, Shishiba Y, Irie M, et al
    Gestational trimester-specific reference ranges for serum thyrotropin and free thyroxine in Japanese.
    Endocr J. 2022 Jul 9. doi: 10.1507/endocrj.EJ22-0237.
    PubMed     Abstract available


    June 2022
  6. YAMAMOTO M, Onoda N, Miyauchi A, Fujishima M, et al
    Gauze blotting technique: a novel method to identify parathyroid glands during thyroid surgery without tissue damage.
    Endocr J. 2022 Jun 25. doi: 10.1507/endocrj.EJ22-0043.
    PubMed     Abstract available


  7. HASHIMOTO K
    Update on subclinical thyroid dysfunction.
    Endocr J. 2022 Jun 22. doi: 10.1507/endocrj.EJ22-0182.
    PubMed     Abstract available


  8. WANG HQ, Li Y, Song X, Ma YQ, et al
    Significance of interstitial fibrosis and p16 in papillary thyroid carcinoma.
    Endocr J. 2022 Jun 18. doi: 10.1507/endocrj.EJ22-0010.
    PubMed     Abstract available


  9. NAKAMURA Y, Yoshihara A, Kiriya M, Kawashima A, et al
    Thyroid stimulating hormone suppresses the expression and activity of cytosolic sulfotransferase 1a1 in thyrocytes.
    Endocr J. 2022 Jun 9. doi: 10.1507/endocrj.EJ22-0055.
    PubMed     Abstract available


  10. PARK E, Kim MS, Noh ES, Lee JE, et al
    Multiple endocrine neoplasia type 2 and autoimmune polyendocrine syndromes (type 1 diabetes mellitus and Graves' disease) in a 16-year-old male with Kabuki syndrome.
    Endocr J. 2022 Jun 8. doi: 10.1507/endocrj.EJ22-0084.
    PubMed     Abstract available


  11. MORITANI S, Takenobu M, Yasunaga M, Kawamoto K, et al
    Surgical indications for upper mediastinal dissection by sternotomy in patients with papillary thyroid carcinoma.
    Endocr J. 2022 Jun 2. doi: 10.1507/endocrj.EJ22-0033.
    PubMed     Abstract available


    April 2022
  12. ITO Y, Hirokawa M, Masuoka H, Higashiyama T, et al
    Prognostic factors for follicular thyroid carcinoma: the importance of vascular invasion.
    Endocr J. 2022 Apr 29. doi: 10.1507/endocrj.EJ22-0077.
    PubMed     Abstract available


  13. ITO Y, Miyauchi A, Fujishima M, Masuoka H, et al
    Prognostic significance of patient age in papillary thyroid carcinoma with no high-risk features.
    Endocr J. 2022 Apr 15. doi: 10.1507/endocrj.EJ22-0056.
    PubMed     Abstract available


  14. KANEKO M, Ohara K, Shikata H
    A case of fatal myxedema coma with electrocardiogram Osborne J-wave in a patient initially diagnosed with hypothyroidism.
    Endocr J. 2022 Apr 9. doi: 10.1507/endocrj.EJ21-0720.
    PubMed     Abstract available


  15. YOSHIHARA A, Yoshimura Noh J, Inoue K, Taguchi J, et al
    Prediction model of Graves' disease in general clinical practice based on complete blood count and biochemistry profile.
    Endocr J. 2022 Apr 5. doi: 10.1507/endocrj.EJ21-0741.
    PubMed     Abstract available


    March 2022
  16. OKAMURA K, Sato K, Fujikawa M, Bandai S, et al
    Iodide-sensitive Graves' hyperthyroidism and the strategy for resistant or escaped patients during potassium iodide treatment.
    Endocr J. 2022 Mar 24. doi: 10.1507/endocrj.EJ21-0436.
    PubMed     Abstract available


  17. KISHIMOTO M, Ishikawa T, Odawara M
    Subacute thyroiditis with liver dysfunction following coronavirus disease 2019 (COVID-19) vaccination: report of two cases and a literature review.
    Endocr J. 2022 Mar 10. doi: 10.1507/endocrj.EJ21-0629.
    PubMed     Abstract available


  18. JOJIMA T, Shinzawa T, Ohira E, Sakurai S, et al
    Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance.
    Endocr J. 2022 Mar 4. doi: 10.1507/endocrj.EJ21-0656.
    PubMed     Abstract available


    February 2022
  19. KAZAKOVA D, Shimamura M, Kurashige T, Hamada K, et al
    Re-evaluation of the role of autophagy in thyroid cancer treatment.
    Endocr J. 2022 Feb 22. doi: 10.1507/endocrj.EJ22-0017.
    PubMed     Abstract available


  20. GAO J, Hu J, Li P, Che K, et al
    Human umbilical cord mesenchymal stem cells alleviate the imbalance of CD4(+) T cells via protein tyrosine phosphatase non-receptor type 2/signal transducer and activator of transcription 3 signaling in ameliorating experimental autoimmune thyroiditis
    Endocr J. 2022 Feb 10. doi: 10.1507/endocrj.EJ20-0695.
    PubMed     Abstract available


  21. MARZOUKI H, Alrowaizen S, Ageel M, Nujoom M, et al
    The long-term impact of neck scar satisfaction among thyroid surgery patients.
    Endocr J. 2022 Feb 5. doi: 10.1507/endocrj.EJ21-0577.
    PubMed     Abstract available


    January 2022
  22. ITO Y, Hirokawa M, Hayashi T, Kihara M, et al
    Clinical outcomes of follicular tumor of uncertain malignant potential of the thyroid: real-world data.
    Endocr J. 2022 Jan 26. doi: 10.1507/endocrj.EJ21-0723.
    PubMed     Abstract available


  23. SUN D, Zhou L, Wang S, Liu T, et al
    Effect of Di-(2-ethylhexyl) phthalate on the hypothalamus-pituitary-thyroid axis in adolescent rat.
    Endocr J. 2022;69:217-224.
    PubMed     Abstract available


    December 2021
  24. NODA T, Miyauchi A, Ito Y, Kudo T, et al
    Observational management of papillary microcarcinoma appearing in the remnant thyroid after hemithyroidectomy.
    Endocr J. 2021 Dec 25. doi: 10.1507/endocrj.EJ21-0557.
    PubMed     Abstract available


  25. NAKAMURA S, Kido N, Watanabe M, Ohmachi Y, et al
    Analysis of thyroid function in Japanese patients with coronavirus disease 2019.
    Endocr J. 2021 Dec 24. doi: 10.1507/endocrj.EJ21-0609.
    PubMed     Abstract available


    November 2021
  26. SUNADA N, Hanayama Y, Yamamoto K, Nakano Y, et al
    Clinical utility of urinary levels of catecholamines and their fraction ratios related to heart rate and thyroid function.
    Endocr J. 2021 Nov 3. doi: 10.1507/endocrj.EJ21-0488.
    PubMed     Abstract available


  27. KURE S, Chiba T, Ebina A, Toda K, et al
    Correlation between low expression of protein disulfide isomerase A3 and lymph node metastasis in papillary thyroid carcinoma and poor prognosis: a clinicopathological study of 1,139 cases with long-term follow-up.
    Endocr J. 2021 Nov 2. doi: 10.1507/endocrj.EJ21-0394.
    PubMed     Abstract available


    October 2021
  28. FUKUSHITA M, Watanabe N, Yoshimura Noh J, Yoshihara A, et al
    A case of macro-TSH consisting of IgA-bound TSH.
    Endocr J. 2021;68:1241-1246.
    PubMed     Abstract available


  29. SUZUKI A, Hirokawa M, Kanematsu R, Tanaka A, et al
    B-cell to T-cell ratio as a novel indicator in flow cytometry in the diagnosis of thyroid lymphoma.
    Endocr J. 2021 Oct 21. doi: 10.1507/endocrj.EJ21-0451.
    PubMed     Abstract available


  30. YAMAGUCHI Y, Uchimura K, Takahashi K, Ishii T, et al
    Hyperthyroidism exacerbates ischemic reperfusion injury in the kidney.
    Endocr J. 2021 Oct 9. doi: 10.1507/endocrj.EJ21-0395.
    PubMed     Abstract available


  31. FUKATA S, Ito M, Nishikawa M, Kasahara T, et al
    Hypothyroidism due to nephrotic syndrome: a notable clinical entity.
    Endocr J. 2021 Oct 6. doi: 10.1507/endocrj.EJ21-0387.
    PubMed     Abstract available


    September 2021
  32. CAO X, Zhu J, Li X, Ma Y, et al
    Expression of CXCR4 and CXCR7 in papillary thyroid carcinoma and adjacent tissues and their relationship with pathologic indicators of tumor aggressiveness.
    Endocr J. 2021 Sep 28. doi: 10.1507/endocrj.EJ21-0076.
    PubMed     Abstract available


  33. ZHENG H, Fu Q, Ma K, Shi S, et al
    Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling.
    Endocr J. 2021 Sep 25. doi: 10.1507/endocrj.EJ20-0498.
    PubMed     Abstract available


  34. OHBA K, Sasaki S, Misawa Nakamura H, Matsushita A, et al
    Clinical outcomes of 34 patients with resistance to thyroid hormone beta: a twenty-year experience in Japan.
    Endocr J. 2021 Sep 22. doi: 10.1507/endocrj.EJ21-0390.
    PubMed     Abstract available


  35. OKAMURA K, Ibayashi H, Sato K, Fujikawa M, et al
    A case of Graves' disease presenting with internal ophthalmoplegia during methylmercaptoimidazole treatment.
    Endocr J. 2021 Sep 18. doi: 10.1507/endocrj.EJ21-0340.
    PubMed     Abstract available


  36. KAMMA H, Kameyama K, Kondo T, Imamura Y, et al
    Pathological diagnosis of general rules for the description of thyroid cancer by Japanese Society of Thyroid Pathology and Japan Association of Endocrine Surgery.
    Endocr J. 2021 Sep 15. doi: 10.1507/endocrj.EJ21-0388.
    PubMed     Abstract available


  37. MINAKATA M, Ito M, Kishi T, Hada M, et al
    The magnitude of increased Levothyroxine dose during pregnancy in patients on thyroid-stimulating hormone (TSH) suppression treatment after total thyroidectomy for papillary carcinoma.
    Endocr J. 2021 Sep 14. doi: 10.1507/endocrj.EJ21-0109.
    PubMed     Abstract available


  38. LIU H, Yao XY, Zheng ZQ, Chen SJ, et al
    Analysis of risk factors for posterior laryngeal recurrent nerve metastasis in micropapillary thyroid carcinoma.
    Endocr J. 2021 Sep 7. doi: 10.1507/endocrj.EJ21-0073.
    PubMed     Abstract available


    August 2021
  39. FUKUSHIMA M, Fukunari N, Murakami T, Kunii Y, et al
    Reconfirmation of the accuracy of the taller-than-wide sign in multicenter collaborative research in Japan.
    Endocr J. 2021;68:897-904.
    PubMed     Abstract available


  40. YOKOMICHI H, Mochizuki M, Kojima R, Horiuchi S, et al
    Mother's iodine exposure and infants' hypothyroidism: the Japan environment and children's study.
    Endocr J. 2021 Aug 26. doi: 10.1507/endocrj.EJ21-0168.
    PubMed     Abstract available


  41. TOI N, Kurajoh M, Miyaoka D, Nagata Y, et al
    Bexarotene-induced central hypothyroidism assessed by TRH stimulation test in cutaneous T-cell lymphoma patients.
    Endocr J. 2021 Aug 25. doi: 10.1507/endocrj.EJ21-0313.
    PubMed     Abstract available


  42. KIM J, Shin JH, Oh YL, Hahn SY, et al
    Approach to Bethesda system category III thyroid nodules according to US-risk stratification.
    Endocr J. 2021 Aug 18. doi: 10.1507/endocrj.EJ21-0300.
    PubMed     Abstract available


    July 2021
  43. WATANABE N, Yoshimura Noh J, Akamizu T, Yamada M, et al
    Survey of the actual administration of thiamazole for hyperthyroidism in Japan by the Japan Thyroid Association.
    Endocr J. 2021 Jul 29. doi: 10.1507/endocrj.EJ21-0238.
    PubMed     Abstract available


  44. KIHARA M, Miyauchi A, Hirokawa M, Masuoka H, et al
    Long-term outcomes of cytologically benign thyroid tumors: a retrospective analysis of 3,102 patients at a single institution.
    Endocr J. 2021 Jul 16. doi: 10.1507/endocrj.EJ21-0252.
    PubMed     Abstract available


  45. WATANABE D, Yagasaki H, Narusawa H, Saito T, et al
    Screening of frequent variants associated with congenital hypothyroidism: a comparison with next generation sequencing.
    Endocr J. 2021 Jul 8. doi: 10.1507/endocrj.EJ21-0353.
    PubMed     Abstract available


  46. ITO Y, Hirokawa M, Kousaka K, Ito M, et al
    Diagnosis and management of hyalinizing trabecular tumor of the thyroid: a single-institution experience.
    Endocr J. 2021 Jul 6. doi: 10.1507/endocrj.EJ21-0143.
    PubMed     Abstract available


  47. OBA T, Maeno K, Amitani M, Shimizu T, et al
    Prognostic significance of neutrophil-to-lymphocyte ratio for long-term outcomes in patients with poorly differentiated thyroid cancer.
    Endocr J. 2021 Jul 2. doi: 10.1507/endocrj.EJ21-0237.
    PubMed     Abstract available


    June 2021
  48. FUJISHIMA M, Miyauchi A, Ito Y, Kudo T, et al
    Evaluation of the diagnostic utility of the aminotransferase/lactate dehydrogenase ratio for the suspension of tissue specimens during thyroid surgery for the identification of parathyroid tissue.
    Endocr J. 2021 Jun 15. doi: 10.1507/endocrj.EJ21-0128.
    PubMed     Abstract available


  49. HAYASHI T, Akiyama N, Kanematsu R, Higuchi M, et al
    Potential role of mobile rapid on-site evaluation((R)) in thyroid fine-needle aspiration cytology to reduce delayed repeated aspiration.
    Endocr J. 2021 Jun 12. doi: 10.1507/endocrj.EJ21-0010.
    PubMed     Abstract available


  50. MAO Y, Huo Y, Li J, Zhao Y, et al
    circRPS28 (hsa_circ_0049055) is a novel contributor for papillary thyroid carcinoma by regulating cell growth and motility via functioning as ceRNA for miR-345-5p to regulate frizzled family receptor 8 (FZD8).
    Endocr J. 2021 Jun 10. doi: 10.1507/endocrj.EJ21-0072.
    PubMed     Abstract available


  51. HANAI S, Uchimura K, Takahashi K, Ishii T, et al
    Hypoxia-induced thyroid hormone receptor expression regulates cell-cycle progression in renal tubule epithelial cells.
    Endocr J. 2021 Jun 8. doi: 10.1507/endocrj.EJ21-0245.
    PubMed     Abstract available


  52. LI X, Yang S, Zhao C, Yang J, et al
    CircHACE1 functions as a competitive endogenous RNA to curb differentiated thyroid cancer progression by upregulating Tfcp2L1 through adsorbing miR-346.
    Endocr J. 2021 Jun 4. doi: 10.1507/endocrj.EJ20-0806.
    PubMed     Abstract available


    May 2021
  53. OKADA J, Isoda A, Hoshi H, Watanabe T, et al
    Free triiodothyronine /free thyroxine ratio as an index of deiodinase type 1 and 2 activities negatively correlates with casual serum insulin levels in patients with type 2 diabetes mellitus.
    Endocr J. 2021 May 11. doi: 10.1507/endocrj.EJ21-0169.
    PubMed     Abstract available


  54. KAKUDO K, Liu Z, Bai Y, Li Y, et al
    How to identify indolent thyroid tumors unlikely to recur and cause cancer death immediately after surgery-Risk stratification of papillary thyroid carcinoma in young patients.
    Endocr J. 2021 May 11. doi: 10.1507/endocrj.EJ21-0018.
    PubMed     Abstract available


  55. MIZOKAMI T, Hamada K, Maruta T, Higashi K, et al
    Utility of outpatient fractionated radioiodine therapy for Graves disease involving a large goiter measuring more than 100 mL in volume.
    Endocr J. 2021 May 11. doi: 10.1507/endocrj.EJ20-0836.
    PubMed     Abstract available


  56. IIJIMA T, Jojima T, Hosonuma S, Ohhira E, et al
    Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome 22q11.2 deletion syndrome complicated by Graves' disease: longitudinal changes in the number of subsets of CD4 and CD8 lymphocytes after thyroidectomy.
    Endocr J. 2021 May 11. doi: 10.1507/endocrj.EJ20-0717.
    PubMed     Abstract available


    April 2021
  57. DING X, Zhao Y, Zhu CY, Wu LP, et al
    The association between subclinical hypothyroidism and metabolic syndrome: an update meta-analysis of observational studies.
    Endocr J. 2021 Apr 21. doi: 10.1507/endocrj.EJ20-0796.
    PubMed     Abstract available


  58. SAKAMOTO A, Hirokawa M, Ito M, Naganuma H, et al
    Introduction of histological classification and cytology reporting format of the Japanese General Rules for the Description of Thyroid Cancer with a special focus on the differences of the WHO Histological Classification and The Bethesda System of Thy
    Endocr J. 2021 Apr 13. doi: 10.1507/endocrj.EJ21-0077.
    PubMed     Abstract available


  59. TAGAMI T
    An overview of thyroid function tests in subjects with resistance to thyroid hormone and related disorders.
    Endocr J. 2021 Apr 6. doi: 10.1507/endocrj.EJ21-0059.
    PubMed     Abstract available


    March 2021
  60. LI H, Yang M, Shen H, Wang S, et al
    Severe metabolic disorders coexisting with Werner syndrome: a case report.
    Endocr J. 2021;68:261-267.
    PubMed     Abstract available


  61. HORIGUCHI K, Yoshida Y, Iwaku K, Emoto N, et al
    Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults.
    Endocr J. 2021 Mar 23. doi: 10.1507/endocrj.EJ20-0692.
    PubMed     Abstract available


  62. ITO Y, Hirokawa M, Fujishima M, Masuoka H, et al
    Prognostic significance of vascular invasion and cell-proliferation activity in widely invasive follicular carcinoma of the thyroid.
    Endocr J. 2021 Mar 20. doi: 10.1507/endocrj.EJ21-0064.
    PubMed     Abstract available


  63. LIU Y, Chen G, Wang B, Wu H, et al
    Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
    Endocr J. 2021 Mar 13. doi: 10.1507/endocrj.EJ20-0726.
    PubMed     Abstract available


  64. SHIMATSU A, Nakamura A, Takahashi Y, Fujio S, et al
    Preoperative and long-term efficacy and safety of lanreotide autogel in patients with thyrotropin-secreting pituitary adenoma: a multicenter, single-arm, phase 3 study in Japan.
    Endocr J. 2021 Mar 11. doi: 10.1507/endocrj.EJ20-0707.
    PubMed     Abstract available


    February 2021
  65. HIRUMA M, Sasano Y, Watanabe N, Yoshihara A, et al
    Propylthiouracil-induced otitis media with anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report and review of the literature.
    Endocr J. 2021;68:145-151.
    PubMed     Abstract available


  66. WANG D, Zheng Y
    Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Endocr J. 2021 Feb 20. doi: 10.1507/endocrj.EJ20-0353.
    PubMed     Abstract available


  67. TANIMURA Y, Kiriya M, Kawashima A, Mori H, et al
    Regulation of solute carrier family 26 member 7 (Slc26a7) by thyroid stimulating hormone in thyrocytes.
    Endocr J. 2021 Feb 14. doi: 10.1507/endocrj.EJ20-0502.
    PubMed     Abstract available


  68. NISHIHARA E, Ito Y, Kudo T, Ito M, et al
    Favorable outcomes of papillary thyroid microcarcinoma concurrent with Graves' disease after radioactive iodine therapy.
    Endocr J. 2021 Feb 6. doi: 10.1507/endocrj.EJ20-0753.
    PubMed     Abstract available


    January 2021
  69. FUKUDA N, Toda K, Wang X, Ohmoto A, et al
    Prognostic significance of 8 weeks' relative dose intensity of lenvatinib in treatment of radioiodine-refractory differentiated thyroid cancer patients.
    Endocr J. 2021 Jan 28. doi: 10.1507/endocrj.EJ20-0754.
    PubMed     Abstract available


  70. YAMADA Y, Orita M, Matsunaga H, Yamaguchi T, et al
    Risk perception regarding implementation of iodine thyroid blocking during a nuclear disaster of mothers living near a nuclear power station in Japan.
    Endocr J. 2021 Jan 21. doi: 10.1507/endocrj.EJ20-0627.
    PubMed     Abstract available


  71. DAMIAO CP, Montero JRG, Moran MBH, de Oliveira Marcal E Silva Carvalho ME, et al
    Application of thermography in the diagnostic investigation of thyroid nodules.
    Endocr J. 2021 Jan 21. doi: 10.1507/endocrj.EJ20-0541.
    PubMed     Abstract available


  72. MA J, Kan Z
    Circular RNA circ_0008274 enhances the malignant progression of papillary thyroid carcinoma via modulating solute carrier family 7 member 11 by sponging miR-154-3p.
    Endocr J. 2021 Jan 19. doi: 10.1507/endocrj.EJ20-0453.
    PubMed     Abstract available


  73. SPEER G, Somogyi P
    Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).
    Endocr J. 2021 Jan 19. doi: 10.1507/endocrj.EJ20-0443.
    PubMed     Abstract available


  74. WATANABE T, Temma Y, Okada J, Yamada E, et al
    In patients with type 2 diabetes the presence of Hashimoto's thyroiditis reduces the beneficial effect of dipeptidyl peptidase-4 inhibitor on plasma glucose control.
    Endocr J. 2021 Jan 7. doi: 10.1507/endocrj.EJ20-0620.
    PubMed     Abstract available


    December 2020
  75. TAKESHIMA K, Li Y, Kakudo K, Hirokawa M, et al
    Proposal of diagnostic criteria for IgG4-related thyroid disease.
    Endocr J. 2020 Dec 12. doi: 10.1507/endocrj.EJ20-0557.
    PubMed     Abstract available


    November 2020
  76. TAKAHASHI S, Ito M, Masaki Y, Hada M, et al
    Association between serum thyroid hormone balance and thyroid volume in patients treated with levothyroxine monotherapy for hypothyroidism.
    Endocr J. 2020 Nov 25. doi: 10.1507/endocrj.EJ20-0542.
    PubMed     Abstract available


  77. MIZUNO S, Inaba H, Kobayashi KI, Kubo K, et al
    A case of postpartum thyroiditis following SARS-CoV-2 infection.
    Endocr J. 2020 Nov 12. doi: 10.1507/endocrj.EJ20-0553.
    PubMed     Abstract available


    October 2020
  78. YUAN X, Wang J, Gao Y, Wang H, et al
    Impact of maternal thyroid hormone in late pregnancy on adverse birth outcomes: A retrospective cohort study in China.
    Endocr J. 2020 Oct 27. doi: 10.1507/endocrj.EJ20-0377.
    PubMed     Abstract available


  79. LI S, Li W, Sheng B, Zhu X, et al
    Relationship between thyroid disorders and uterine fibroids among reproductive-age women.
    Endocr J. 2020 Oct 8. doi: 10.1507/endocrj.EJ20-0340.
    PubMed     Abstract available


  80. INABA H, Ariyasu H, Iwakura H, Kurimoto C, et al
    Distinct clinical features and prognosis between persistent and temporary thyroid dysfunctions by immune-checkpoint inhibitors.
    Endocr J. 2020 Oct 3. doi: 10.1507/endocrj.EJ20-0371.
    PubMed     Abstract available


  81. TSUNEMI A, Uchida T, Kuroda K, Ikemoto Y, et al
    Effect of thyroxine treatment on pregnancy outcomes in infertile Japanese women with TSH levels between 2.5 muIU/mL and the upper reference limit: a retrospective study.
    Endocr J. 2020 Oct 1. doi: 10.1507/endocrj.EJ20-0380.
    PubMed     Abstract available


    April 2020
  82. KO J, Kim JY, Kim JW, Yoon JS, et al
    Anti-oxidative and anti-adipogenic effects of caffeine in an in vitro model of Graves' orbitopathy.
    Endocr J. 2020;67:439-447.
    PubMed     Abstract available


    February 2020
  83. ZHU XH, Zhou JN, Qian YY, Yang K, et al
    Diagnostic values of thyroglobulin in lymph node fine-needle aspiration washout: a systematic review and meta-analysis diagnostic values of FNA-Tg.
    Endocr J. 2020;67:113-123.
    PubMed     Abstract available


  84. SHIMAZAKI S, Kazukawa I, Mori K, Kihara M, et al
    Factors predicting endocrine late effects in childhood cancer survivors from a Japanese hospital.
    Endocr J. 2020;67:131-140.
    PubMed     Abstract available


    January 2020
  85. UCHIDA T, Yamaguchi H, Kushima C, Yonekawa T, et al
    Elevated levels of circulating fibroblast growth factor 23 with hypercalcemia following discontinuation of denosumab.
    Endocr J. 2020;67:31-35.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: